Title: Eric Lefebvre - Innovator in Therapeutic Applications
Introduction
Eric Lefebvre is an inventor based in South San Francisco, CA (US). He is currently associated with Tobira Therapeutics, Inc. Although he does not hold any granted patents, his work focuses on innovative therapeutic applications.
Latest Patent Applications
Eric Lefebvre has submitted several patent applications, including one titled "CENICRIVIROC FOR THE TREATMENT OF FIBROSIS." This application outlines methods for treating fibrosis or fibrotic diseases by administering a therapeutically effective amount of cenicriviroc or its salts. The conditions addressed include liver fibrosis, renal fibrosis, and non-cirrhotic hepatic fibrosis associated with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). Another application under the same title discusses the use of cenicriviroc in treating inflammation and connective tissue diseases, such as fibrosis, peritonitis, and liver injury.
Conclusion
Eric Lefebvre is making significant contributions to the field of therapeutic innovations, particularly in the treatment of fibrosis and related conditions. His ongoing research and patent applications reflect his commitment to advancing medical science.